Dimensional Fund Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
JT
RCM
DTC
Dimensional Fund Advisors's PCVX Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Vaxcyte (PCVX) stake by 218% in Q2 2026, buying an estimated $44.5M and bringing the position to 1,194,754 shares worth $69.4M. The position accounts for 0.01% of the portfolio, ranked #1412.
Dimensional Fund Advisors first reported a position in PCVX in Q2 2022 and has held it in 16 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- Dimensional Fund Advisors held 1,194,754 shares of Vaxcyte worth $69.4M as of Q2 2026.
- Dimensional Fund Advisors bought 818,982 Vaxcyte shares in Q2 2026, an estimated $44.5M.
- Vaxcyte made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1412 holding.
- Dimensional Fund Advisors first reported a position in Vaxcyte in Q2 2022 and has held it in 16 quarters since.
- 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.